3+3 Design [Design Issues]

posted by Pharma_88 – India, 2020-01-07 07:09 (421 d 11:25 ago) – Posting: # 21062
Views: 2,427

Hello All,

This is regarding 3+3 design for Phase-I trial. I have searched online and found some articles on design. My Question is that once the group/cohort is completed with 3 patients, whether same patients will be enrolled in next cohort or new patient will be enrolled? Further, in next cohort suppose 1 patient is withdarwn or have some AE then its compulsory to add 3 more patients to inline with multiplication of 3?

Thanks,
Pharma_88

Complete thread:

Activity
 Admin contact
21,361 posts in 4,461 threads, 1,493 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Wednesday 18:34 UTC (Europe/Vienna)

The art and science of asking questions
is the source of all knowledge.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5